Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Bone and Mineral Metabolism
Published in: Journal of Bone and Mineral Metabolism 3/2013

01-05-2013 | Special Report

Justification criteria for vertebral fractures: year 2012 revision

Authors: Satoshi Mori, Satoshi Soen, Hiroshi Hagino, Tetsuo Nakano, Masako Ito, Saeko Fujiwara, Yoshiharu Kato, Yasuaki Tokuhashi, Daisuke Togawa, Naoto Endo, Takeshi Sawaguchi, Committee for Vertebral Fracture Evaluation

Published in: Journal of Bone and Mineral Metabolism | Issue 3/2013

Login to get access

Abstract

Justification Criteria for Vertebral Fractures 2012 version was made based on new clinical findings. Major differences in this version compared to the 1996 version are inclusion of the semiquantitative method (SQ), statements to improve considerations during radiographic analysis, and the need for more detailed evaluation by MRI.
Literature
1.
Orimo H, Sugioka Y, Fukunaga H, et al (1997) Diagnostic criteria for primary osteoporosis: year 1996 revision. Nihon Kotsutaisha Gakkai Zasshi 14:219–233
2.
Chestnut MC, Ross PD, Christiansen C et al (2004) Effects of oral ibandronate administrated daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19:1241–1249CrossRef
3.
Genant HK, Wu CY, vanKuijk C et al (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef
4.
Ettinger B, Black DM, Mitlak BH et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: multiple outcomes of raloxifene evaluation (MORE) investigators. JAMA 282:637–664PubMedCrossRef
5.
Neer RM, Amaud CD, Zaruchetta JR et al (2001) Effects of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1433–1441CrossRef
6.
Yamamoto K, Inoue T, Takahashi H et al (1995) Criteria of pointing and ruled line for measurement of vertebral deformities on X-ray. Orthopedic Surgery 46:5–17
7.
Nakano T, Inaba D, Takada K et al. (2003) Osteoporos Jpn 11:747–750 (in Japanese)
8.
Kato Y, Kaneya K, Wada K et al (2009) Magnetic resonance imaging follow-up study in the evaluation of vertebral fractures in osteoporotic patients-randomized control clinical study. Osteoporos Jpn 17:218–221
9.
Japanese 2011 Guideline for Prevention and Treatment of Osteoporosis. Tokyo: Life Science Publishing; 2011
Metadata
Title
Justification criteria for vertebral fractures: year 2012 revision
Authors
Satoshi Mori
Satoshi Soen
Hiroshi Hagino
Tetsuo Nakano
Masako Ito
Saeko Fujiwara
Yoshiharu Kato
Yasuaki Tokuhashi
Daisuke Togawa
Naoto Endo
Takeshi Sawaguchi
Committee for Vertebral Fracture Evaluation
Publication date
01-05-2013
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 3/2013
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-013-0441-1

Other articles of this Issue 3/2013

Journal of Bone and Mineral Metabolism 3/2013 Go to the issue

Original Article

Increased risk of hip fracture among Japanese hemodialysis patients

Original Article

Consuming breakfast and exercising longer during high school increases bone mineral density in young adult men

Original Article

Non-adherence to anti-osteoporotic medications in Taiwan: physician specialty makes a difference

Original Article

Skeletal effects and growth in children with chronic kidney disease: a 5-year prospective study

Original Article

Prevalence of sarcopenia and associated factors among Thai population

Original Article

The effects of physical activity on apoptosis and lubricin expression in articular cartilage in rats with glucocorticoid-induced osteoporosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits